Jo Nijs1, Amarins J Wijma2, Laurence Leysen3, Roselien Pas3, Ward Willaert3, Wouter Hoelen4, Kelly Ickmans5, C Paul van Wilgen2. 1. Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium; Chronic Pain Rehabilitation, Department of Physical Medicine and Physiotherapy, University Hospital Brussels, Brussels, Belgium. Electronic address: Jo.Nijs@vub.be. 2. Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium; Transcare Transdisciplinary Pain Management Center, Groningen, The Netherlands. 3. Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium. 4. De Berekuyl, Private Practice for Physiotherapy in Oncology & Lymphology, Hierden, The Netherlands; The Berekuyl Academy, Hierden, The Netherlands. 5. Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education & Physiotherapy, Vrije Universiteit Brussel, Brussels, Belgium; Chronic Pain Rehabilitation, Department of Physical Medicine and Physiotherapy, University Hospital Brussels, Brussels, Belgium.
Abstract
BACKGROUND: Pain is one of the most prevalent and debilitating symptom following cancer treatment. OBJECTIVES: This paper entails a practical guide for clinicians willing to apply pain neuroscience education (PNE) in this specific population, or clinical researchers willing to examine the effects of PNE in patients suffering from pain following cancer. RESULTS: Patient-specific information (i.e. beliefs, cognitions, pain memories, social factors) as well as identification of the dominant pain mechanism are needed to tailor the education to the specific needs and beliefs of the patient. Therapists require an in-depth understanding of pain mechanisms, the skills to explain to their patients various pain mechanisms, specific communication skills (e.g. Socratic-style dialogof education) and experience with current evidence-based biopsychosocially-driven pain management strategies for successful implementation of PNE in the clinic. Rather than purely focusing on the biomedical characteristics of pain following cancer (e.g., tissue damage due to past cancer treatment), PNE implies teaching patients about the underlying biopsychosocial mechanisms of pain. Its application is backed-up by mounting evidence supporting the effectiveness of PNE in non-cancer pain populations, and a pilot study in patients having pain following cancer. CONCLUSION: PNE is a potential solution to improve pain outcome in cancer survivors. Further research using sufficiently powered and well-designed randomized clinical trials should be conducted to examine the potential of PNE in patients having pain following cancer.
BACKGROUND:Pain is one of the most prevalent and debilitating symptom following cancer treatment. OBJECTIVES: This paper entails a practical guide for clinicians willing to apply pain neuroscience education (PNE) in this specific population, or clinical researchers willing to examine the effects of PNE in patients suffering from pain following cancer. RESULTS:Patient-specific information (i.e. beliefs, cognitions, pain memories, social factors) as well as identification of the dominant pain mechanism are needed to tailor the education to the specific needs and beliefs of the patient. Therapists require an in-depth understanding of pain mechanisms, the skills to explain to their patients various pain mechanisms, specific communication skills (e.g. Socratic-style dialogof education) and experience with current evidence-based biopsychosocially-driven pain management strategies for successful implementation of PNE in the clinic. Rather than purely focusing on the biomedical characteristics of pain following cancer (e.g., tissue damage due to past cancer treatment), PNE implies teaching patients about the underlying biopsychosocial mechanisms of pain. Its application is backed-up by mounting evidence supporting the effectiveness of PNE in non-cancer pain populations, and a pilot study in patients having pain following cancer. CONCLUSION:PNE is a potential solution to improve pain outcome in cancer survivors. Further research using sufficiently powered and well-designed randomized clinical trials should be conducted to examine the potential of PNE in patients having pain following cancer.
Authors: Jill M Binkley; Susan R Harris; Pamela K Levangie; Marcia Pearl; Janine Guglielmino; Valerie Kraus; Diana Rowden Journal: Cancer Date: 2012-04-15 Impact factor: 6.860
Authors: V Peuckmann; O Ekholm; N K Rasmussen; M Groenvold; P Christiansen; S Møller; J Eriksen; P Sjøgren Journal: Eur J Pain Date: 2008-07-16 Impact factor: 3.931
Authors: Abdullah Sulieman Terkawi; Siny Tsang; Anwar S Alshehri; Dhaifallah S Mulafikh; Abdulrahman A Alghulikah; Saleh F AlDhahri Journal: Saudi J Anaesth Date: 2017-05
Authors: María Torres-Lacomba; Beatriz Navarro-Brazález; Javier Bailón-Cerezo; Fernando Vergara-Pérez; Irene de la Rosa-Díaz; Virginia Prieto-Gómez Journal: Int J Environ Res Public Health Date: 2021-04-22 Impact factor: 3.390
Authors: Astrid Lahousse; Eva Roose; Laurence Leysen; Sevilay Tümkaya Yilmaz; Kenza Mostaqim; Felipe Reis; Emma Rheel; David Beckwée; Jo Nijs Journal: J Clin Med Date: 2021-12-30 Impact factor: 4.241